US Patent Issued to Chia Tai Tianqing Pharmaceutical Group on Nov. 18 for "Quinoline derivative and antibody soft tissue sarcoma combination therapy" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,173, issued on Nov. 18, was assigned to Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (Lianyungang, China).

"Quinoline derivative and antibody soft tissue sarcoma combination therapy" was invented by Di Wu (Changchun, China) and Huan Wang (Lianyungang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the pharmaceutical field, and provides a quinoline derivative and antibody soft tissue sarcoma combination therapy, specifically relating to a use of a therapeutically effective amount of a quinoline derivative compound I or a pharmaceutically acceptable salt thereof in combination with at least one antibody drug i...